Combination pharmacotherapy for macular edema associated with retinal vein occlusion
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Retinal vein occlusion(RVO)is the most prevalent retinal vascular disease except for diabetic retinopathy. Macular edema(ME)is a common complication of RVO which is the major causation of vision loss. The pathogenesis of ME is associated with vascular endothelial growth factor(VEGF)which induced by ischemia and hypoxia after venous obstruction and destruction of blood-retinal barrier caused by inflammation. Therefore, intravitreal injection of anti-VEGF medications or corticosteroids is the most common in the clinical treatment. Due to the two medicines have different react mechanism, duration of efficacy, side effects, and prices etc. There are several researches reported that the combination of two medications in order to treat ME secondary to RVO. This essay is a brief overview of the combination therapies' efficacy, the time of injections and relevant precautions during the therapy process.

    Reference
    Related
    Cited by
Get Citation

Guo Li, Ying Chen, Hong Yan. ,/et al.Combination pharmacotherapy for macular edema associated with retinal vein occlusion. Guoji Yanke Zazhi( Int Eye Sci) 2019;19(2):252-255

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:November 22,2018
  • Revised:December 25,2018
  • Online: January 17,2019